ESRP1 antibody
GTX131373
ApplicationsWestern Blot
Product group Antibodies
TargetESRP1
Overview
- SupplierGeneTex
- Product NameESRP1 antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500-1:3000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsWestern Blot
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration1.29 mg/ml
- ConjugateUnconjugated
- Gene ID54845
- Target nameESRP1
- Target descriptionepithelial splicing regulatory protein 1
- Target synonymsDFNB109, RBM35A, RMB35A, epithelial splicing regulatory protein 1, RNA-binding motif protein 35A, RNA-binding protein 35A
- HostRabbit
- IsotypeIgG
- Protein IDQ6NXG1
- Protein NameEpithelial splicing regulatory protein 1
- Scientific DescriptionESPR1 is an epithelial cell-type-specific splicing regulator (Warzecha et al., 2009 [PubMed 19285943]).[supplied by OMIM]
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Singh B, Sarli VN, Lucci A. Inhibition of resistant triple-negative breast cancer cells with low-dose 6-mercaptopurine and 5-azacitidine. Oncotarget. 2021,12(7):626-637. doi: 10.18632/oncotarget.27922Read this paper
- Singh B, Sarli VN, Kinne HE, et al. Evaluation of 6-mercaptopurine in a cell culture model of adaptable triple-negative breast cancer with metastatic potential. Oncotarget. 2019,10(38):3681-3693. doi: 10.18632/oncotarget.26978Read this paper
- Gökmen-Polar Y, Neelamraju Y, Goswami CP, et al. Splicing factor ESRP1 controls ER-positive breast cancer by altering metabolic pathways. EMBO Rep. 2019,20(2). doi: 10.15252/embr.201846078Read this paper
- Tornillo G, Knowlson C, Kendrick H, et al. Dual Mechanisms of LYN Kinase Dysregulation Drive Aggressive Behavior in Breast Cancer Cells. Cell Rep. 2018,25(13):3674-3692.e10. doi: 10.1016/j.celrep.2018.11.103Read this paper




